SAR127303 is an orally active, selective, competitive covalent inhibitor of monoacylglycerol lipase (MAGL), used to elevate 2-AG levels in the mouse hippocampus; reduce long-term potentiation (LTP) of synaptic transmission and acetylcholine release in the hippocampal CA1 region; produce antinociceptive effects in inflammatory and visceral pain models; and attenuate epileptogenesis.